SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.84-1.7%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bluejeans who wrote (21632)6/1/1998 9:37:00 PM
From: Machaon  Read Replies (1) of 32384
 
a shorter term view:

<< Seragen's fusion proteins have three functional components - a targeting domain that binds with target receptor cells; a "molecular syringe" that pierces the cell membrane; and the toxic portion, which slips inside the cell and destroys it. >>

While we are slowly and painfully losing our arses, on this stock, we might as well see what cards we've been dealt! <g>

This fusion stuff, that LGND gets with Seragen, is some pretty cool stuff. It reminds me of the contraptions that you see in a James Bond movie.

These proteins are some pretty smart dudes, capable of attaching to, and then injecting a poison in a specific type of cell, to kill it.

And.......... all this science is almost totally wasted, right? If, instead of curing cancer, these smart proteins were really smart, they would figure out a way to do what Viagra does, while it is seeking out, and killing cancer cells. Imagine getting your cancer cured, and getting Willy working at the same time! It would be worth billions! <g>

Good luck, Bob

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext